

| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anilkumar Matai Appointed as Director since November 2014 | Director | 10-Nov-2014 | Current |
Bhavana Sharadchandra Doshi Appointed as Director since January 2015 | Director | 13-Jan-2015 | Current |
Deevyesh Jagjivan Radia Appointed as Director since January 2015 | Director | 13-Jan-2015 | Current |
Ganesh Narayan Nayak Appointed as Director since December 2011 | Director | 21-Dec-2011 | Current |
Mayank Jashwantlal Shah Appointed as Director since November 2004 | Director | 04-Nov-2004 | Current |
Nitinkumar Dalsukhray Parekh Appointed as Director since December 2011 | Director | 21-Dec-2011 | Current |
Premium access Complete director detailsUnlock the complete director and KMP records available for Biochem Pharmaceutical Industries Limited Part Ix.
Verified entity values are shown only after access is granted. | |||
People Timeline
Explore the timeline of key personnel in Biochem Pharmaceutical Industries Limited Part Ix's leadership journey.
Loading...
Contact Details
- Address Zydustower,Satellitecrossroad,Sarkhej-Gandhinagarhighway,, Ahmedabad Gujarat, 380015, India
- Telephone Upgrade
- Email Upgrade
- Pin Code 380015
- Country India
- Website biochemgroup.com
Frequently Asked Questions
You can contact Biochem Pharmaceutical Industries Limited Part Ix through their registered address at Zydustower,Satellitecrossroad,Sarkhej-Gandhinagarhighway,, Ahmedabad Gujarat, 380015, India, or via their website at biochemgroup.com. Social media links are also provided where applicable.
The current directors of Biochem Pharmaceutical Industries Limited Part Ix are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- BHAVANA SHARADCHANDRA DOSHI
- GANESH NARAYAN NAYAK
- ANILKUMAR MATAI
- DEEVYESH JAGJIVAN RADIA
- MAYANK JASHWANTLAL SHAH
- NITINKUMAR DALSUKHRAY PAREKH
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.